FDA Clears ION Stent From Boston Scientific The latest generation of drug-eluti

FDA Clears ION Stent From Boston Scientific


The latest generation of drug-eluting stent from Boston Scientific Corp. has been given the nod by the U.S. Food and Drug Administration (FDA). The ION Paclitaxel-eluting platinum chromium coronary stent system is the company’s third-generation drug-eluting stent technology.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters